Fidelity Disruptive Medicine ETF (FMED) is a Fidelity ETF with a 0.50% expense ratio, 78 holdings and $50MM in net assets. Largest sector: Healthcare (98%).
Fee
0.50%
prospectus Sep 24, 2026
Net assets
$50MM
Launched
Jun 12, 2023
Holdings
78
as of Aug 31, 2026
Top 10 weight
37.0%
largest ten holdings
Largest sector
Healthcare
98.4%
Yield
—
Benchmark
—
FMED's holdings are as of Aug 31, 2026.
Healthcare
98.4%
Financial Services
1.6%
1
TXG
10X GENOMICS INC-CLASS A
5.19%
2
—
Net Other Assets
4.44%
3
—
Fidelity Securities Lending Cash Central Fund
4.42%
4
TMO
THERMO FISHER SCIENTIFIC
3.83%
5
DHR
DANAHER
3.73%
6
NTRA
Natera
3.50%
7
ARGX
ARGENX
3.20%
8
LFST
LifeStance Health Group
3.00%
9
RVMD
Revolution Medicines
2.87%
10
ILMN
ILLUMINA
2.82%
11
HTFL
HeartFlow
2.59%
12
DIM
SARTORIUS STEDIM BIOTECH
2.56%
13
MRNA
MODERNA
2.51%
14
ALNY
Alnylam Pharmaceuticals
2.34%
15
COGT
Cogent Biosciences
2.31%
16
ISRG
INTUITIVE SURGICAL
2.05%
17
ASND
Ascendis Pharma A/S
1.97%
18
KYMR
Kymera Therapeutics
1.96%
19
INSM
Insmed
1.84%
20
PCVX
Vaxcyte
1.84%
21
KNSA
Kiniksa Pharmaceuticals International Class A
1.83%
22
EW
EDWARDS LIFESCIENCES
1.76%
23
WST
WEST PHARMACEUTICAL SERVICES
1.72%
24
VEEV
VEEVA SYSTEMS CLASS A
1.66%
25
UCB
United Community Banks /GA
1.60%
1–25 of 78
Funds listed by how much of their largest holdings they share with FMED — not a ranking.
Data from Fidelity; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.